News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Chardonnet Laurent
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/25/2023 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Bought 5,000 shares
@ $5.5, valued at
$27.5k
|
|
02/09/2023 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 135,000 options to buy
@ $7.2, valued at
$972k
|
|
12/22/2022 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 75,000 options to buy
@ $4.9, valued at
$367.5k
|
|
12/12/2022 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Bought 10,000 shares
@ $4.76, valued at
$47.6k
|
|
06/01/2022 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Bought 10,000 shares
@ $4.23, valued at
$42.3k
|
|
03/22/2022 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 6,500 shares
@ $7.51, valued at
$48.8k
|
|
02/17/2022 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 90,000 options to buy
@ $10.58, valued at
$952.2k
|
|
12/14/2021 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 5,000 shares
@ $12.28, valued at
$61.4k
|
|
12/01/2021 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Prelude Therapeutics Inc
Txns:
| Granted 180,000 options to buy
@ $13.75, valued at
$2.5M
|
|
12/01/2021 |
3
| Chardonnet Laurent (CFO) has filed a Form 3 on Prelude Therapeutics Inc |
02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2020 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Axcella Health Inc.
Txns:
| Bought 3,000 shares
@ $4.94, valued at
$14.8k
|
|
01/28/2020 |
4
| Chardonnet Laurent (CFO) has filed a Form 4 on Axcella Health Inc.
Txns:
| Bought 313 shares
@ $4.92, valued at
$1.5k
Bought 352 shares
@ $4.94, valued at
$1.7k
|
|
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/25/2019 |
3
| Chardonnet Laurent (CFO) has filed a Form 3 on Axcella Health Inc. |
04/01/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/09/2015 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 1,152 shares
@ $0 Granted 6,818 options to buy
@ $73.21, valued at
$499.1k
Granted 1,396 options to buy
@ $73.21, valued at
$102.2k
Granted 4,405 options to buy
@ $73.21, valued at
$322.5k
Granted 1,365 options to buy
@ $73.21, valued at
$99.9k
|
|
05/14/2014 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 2,058 shares
@ $54, valued at
$111.1k
|
|
05/06/2014 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 34,000 shares
@ $51.55, valued at
$1.8M
Exercised 14,594 options to buy
@ $9.41, valued at
$137.3k
Exercised 19,406 options to buy
@ $9.41, valued at
$182.6k
|
|
02/18/2014 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 98,334 shares
@ $66.28, valued at
$6.5M
Exercised 25,523 options to buy
@ $8.99, valued at
$229.5k
Exercised 3,888 options to buy
@ $3.11, valued at
$12.1k
Exercised 14,477 options to buy
@ $8.99, valued at
$130.1k
Exercised 3,334 options to buy
@ $6.95, valued at
$23.2k
Exercised 8,874 options to buy
@ $11.98, valued at
$106.3k
Exercised 31,126 options to buy
@ $11.98, valued at
$372.9k
Exercised 11,112 options to buy
@ $3.11, valued at
$34.6k
|
|
01/23/2014 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 1,135 shares
@ $0 Granted 1,143 options to buy
@ $64.55, valued at
$73.8k
Granted 6,943 options to buy
@ $64.55, valued at
$448.2k
|
|
09/09/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/12/2013 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 6,601 options to buy
@ $18.32, valued at
$120.9k
Granted 33,399 options to buy
@ $18.32, valued at
$611.9k
|
|
07/06/2012 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 5,586 shares
@ $25.1, valued at
$140.2k
Sold 27,300 shares
@ $25.11, valued at
$685.5k
Sold 2,214 shares
@ $25.12, valued at
$55.6k
Sold 600 shares
@ $25.13, valued at
$15.1k
Exercised 35,700 options to buy
@ $7.09, valued at
$253.1k
|
|
07/03/2012 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 36,666 shares
@ $24.15, valued at
$885.5k
Exercised 36,666 options to buy
@ $6.95, valued at
$254.8k
|
|
05/01/2012 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 13,976 shares
@ $22.7, valued at
$317.3k
|
|
01/23/2012 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 5,813 options to buy
@ $17.79, valued at
$103.4k
Granted 34,187 options to buy
@ $17.79, valued at
$608.2k
|
|
06/23/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/09/2011 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Sold 5,343 shares
@ $19.55, valued at
$104.5k
|
|
04/08/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/27/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/10/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/20/2010 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 5,833 options to buy
@ $13.34, valued at
$77.8k
Granted 167 options to buy
@ $13.34, valued at
$2.2k
|
|
01/25/2010 |
4
| Chardonnet Laurent (Vice President and Treasurer) has filed a Form 4 on INCYTE CORP
Txns:
| Granted 14,594 options to buy
@ $9.41, valued at
$137.3k
Granted 19,406 options to buy
@ $9.41, valued at
$182.6k
|
|
|
|